These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11177661)

  • 1. Low-molecular weight heparins in coronary artery disease.
    Hunt D
    Curr Atheroscler Rep; 2001 Mar; 3(2):163-8. PubMed ID: 11177661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
    Ageno W; Turpie AG
    CMAJ; 2002 Apr; 166(7):919-24. PubMed ID: 11949991
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
    Brener SJ
    Cleve Clin J Med; 2000 Jan; 67(1):59-65. PubMed ID: 10645678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparins in the management of acute coronary syndromes.
    Zed PJ; Tisdale JE; Borzak S
    Arch Intern Med; 1999 Sep; 159(16):1849-57. PubMed ID: 10493315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparins for acute coronary syndromes: an emergency medicine perspective.
    Gonzalez ER
    Pharmacotherapy; 1999 Sep; 19(9 Pt 2):155S-160S. PubMed ID: 10610006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department.
    Goodman SG
    J Emerg Med; 2000 Oct; 19(3 Suppl):3S-11S. PubMed ID: 11050378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparins and coronary artery disease.
    Zed PJ
    Curr Cardiol Rep; 2000 Jan; 2(1):61-8. PubMed ID: 10980874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes.
    Rosito GA; Silva OB; Ribeiro JP
    Arq Bras Cardiol; 2001 Aug; 77(2):184-95. PubMed ID: 11514830
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-molecular-weight heparins in the treatment of acute coronary syndromes.
    Turpie AG; Antman EM
    Arch Intern Med; 2001 Jun; 161(12):1484-90. PubMed ID: 11427095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
    Kaul S; Shah PK
    J Am Coll Cardiol; 2000 Jun; 35(7):1699-712. PubMed ID: 10841215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reliable anticoagulation in acute myocardial infarction. Acute coronary syndromes: advances with low-molecular heparin therapy].
    Z Kardiol; 1998 Dec; 87(12 Suppl Akute Koro):1-4. PubMed ID: 9884738
    [No Abstract]   [Full Text] [Related]  

  • 14. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
    Magee KD; Sevcik W; Moher D; Rowe BH
    Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants in acute coronary syndromes.
    Turpie AG
    Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of low-molecular-weight heparins in cardiovascular medicine.
    Hödl R; Klein W
    J Clin Pharm Ther; 2003 Oct; 28(5):371-8. PubMed ID: 14632961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins in ischemic heart disease.
    Yan AT; Goodman SG
    Curr Opin Cardiol; 2004 Jul; 19(4):309-16. PubMed ID: 15218388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
    Sätre H; Holmvang L; Wagner GS; Lindahl B; Wallentin L
    Eur Heart J; 1999 May; 20(9):645-52. PubMed ID: 10208784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparins in acute ischaemic syndromes.
    White HD; Ellis CJ; French JK
    Aust N Z J Med; 1998 Aug; 28(4):555-7. PubMed ID: 9777139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.